Will the FDA approve COMP360 Psilocybin for Treatment-Resistant Depression before Mar 1, 2027?
YES means Before Mar 1, 2027
- 24h volume
- 0
- 2,885 lifetime
- Open interest
- 2,316
- Spread
- 4¢
- 5 × 23 at the touch
- 24h range
- –
A YES contract costs 75¢ and pays $1 if it happens.
costs 29¢
An independent read of this market
Generated by an AI analyst from live exchange data and public web sources. Research and analytics, not investment advice. Markets can move after this was written.
Price history
YES price per candle with the bid/ask band, volume underneath. Times in UTC.
Order book
Resting orders, both sides shown as YES prices. Bars are size.
Order book unavailable.
How this market resolves
Verbatim from Kalshi. Read this before the price.
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Mar 1, 2027, then the market resolves to Yes.
- opened
- May 16 · 2:35 AM UTC
- closes
- Mar 1, 2027 · 4:59 AM UTC · may close early
- settles by
- Jan 1, 2028 · 3:00 PM UTC
- ticker
- KXFDAAPPROVALDATECMPS-360-27MAR01
Other outcomes in this event
Outcomes in this event settle independently.
Prices are YES cost in cents and approximate the market’s implied probability. Data is read live from the Kalshi Trade API on every page load. galdor.xyz places no orders and holds no positions. Research and analytics, not investment advice.